Trial · NCT00671060
Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy
NCT00671060, Phase 3, Completed, Gynuity Health Projects; results first posted 2013-05-06
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy. Trials, record NCT00671060. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00671060
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy
- NCT number
- NCT00671060
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 153 participants, actual
- Lead sponsor
- Gynuity Health Projects
- Conditions
- Intrauterine Fetal Demise
- Interventions
- Misoprostol, Misoprostol
- First posted
- 2008-05-02
- Last updated
- 2013-05-08
- Results first posted
- 2013-05-06
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Successful Expulsion of Fetus and Placenta Within 48 Hours | 48 hours |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Successful Expulsion of Fetus and Placenta Within 48 Hours | 48 hours | One woman assigned to the 200μg arm was determined to be ineligible after enrollment due to a gestational age less than 14 weeks. She was not included in the analysis. One woman in the 100mcg arm was withdrawn from the study due to preeclampsia. She was included in the analysis as a failed induction. | participants | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Successful Expulsion of Fetus and Placenta Within 48 Hours | 200 Mcg | 60 | participants | ||
| Successful Expulsion of Fetus and Placenta Within 48 Hours | 100 Mcg | 47 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | 200 Mcg | 77 | |
| Overall Study | STARTED | 100 Mcg | 76 | |
| Overall Study | COMPLETED | 200 Mcg | 76 | |
| Overall Study | COMPLETED | 100 Mcg | 75 | |
| Overall Study | NOT COMPLETED | 200 Mcg | 1 | |
| Overall Study | NOT COMPLETED | 100 Mcg | 1 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Other adverse event | Surgical and medical procedures | 200 Mcg | 1 | 77 | 1 |
| other | Other adverse event | Surgical and medical procedures | 100 Mcg | 0 | 76 | 0 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | 200 Mcg | ||
| Total, all-cause mortality | 100 Mcg | ||
| Total, other adverse events | 200 Mcg | 1 | 77 |
| Total, other adverse events | 100 Mcg | 0 | 76 |
| Total, serious adverse events | 200 Mcg | 0 | 77 |
| Total, serious adverse events | 100 Mcg | 0 | 76 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01FD003107 | MISOPROSTOL FOR TREATMENT OF FETAL DEATH AT 14-28 WEEKS PHASE III | WINIKOFF, BEVERLY | GYNUITY HEALTH PROJECTS | FOOD AND DRUG ADMINISTRATION | 2007 to 2011 |
Source NIH RePORTER
Trial comparisons2
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| 200 Mcg vs 100 Mcg: Successful Expulsion of Fetus and Placenta Within 48 Hours | Trial comparisons |
| 200 Mcg vs 100 Mcg: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00671060
GET https://conductscience.org/api/trials/v1/NCT00671060/registered